Report updated Apr 24, 2026

Overview · Full Intel report in progress

Play Store →

Gluco AI Diabetes Food Tracker is an established medical app that is completely free. With a 4.8/5 rating from 166 reviews, it shows polarized user reception.

What is Gluco AI Diabetes Food Tracker?

Gluco AI is a medical tracking tool designed to assist users in managing diabetes and prediabetes through AI-driven dietary analysis. The app claims to provide real-time blood sugar impact predictions and personalized health recommendations based on user input.

Current Momentum

v3 · 4d ago

Intense

Last updated 4d ago. 5 versions tracked.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

Rating Pulse 🇺🇸

What makes this app unique?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

AI Food Impact PredictionStandard

Uses photo recognition to estimate the potential blood sugar impact and carb count of meals.

Personalized RecommendationsStandard

Provides tailored meal suggestions and exercise prompts based on real-time glucose data.

A1C TrackingStandard

Includes a 90-day plan designed to help users monitor and manage their A1C levels.

How much does it cost?

Free

Who Built It?

Srinjay Verma app icon 1
Srinjay Verma app icon 2
Srinjay Verma app icon 3
Srinjay Verma app icon 4

Srinjay Verma

(115)

Empowering individuals to manage complex health and lifestyle goals through AI-driven predictive tracking and conversational coaching.

Portfolio

8

Apps

Free 7
Lifestyle57%
Social Networking14%
Education14%

Who is Srinjay Verma?

Srinjay Verma operates as an AI-first utility lab, deploying specialized tools that leverage computer vision and conversational AI to address high-friction personal health and lifestyle challenges. The portfolio's strategic focus has shifted toward 'coaching' interfaces—applying a consistent predictive analysis framework to diverse verticals like diabetes management and behavioral habit-breaking. This pivot from general social networking toward high-intent medical and lifestyle utilities suggests a disciplined move into categories where AI provides immediate, measurable user value.

Who is Srinjay Verma for?

  • Individuals managing chronic health conditions
  • Language learners
  • Students seeking AI-assisted habit or academic management
Steady

Portfolio momentum

Released 3 updates across the portfolio in the last 6 months, with the most recent major release occurring only 4 days ago.

Last release · 4d agoActive apps · 4Abandoned · 2

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

Analysis in progress, available soon

What is the competitive landscape for Gluco AI Diabetes Food Tracker?

How's The Medical Market?

How does it evolve in the Medical market?

ChartRankChange
Grossing#97NEW

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for Gluco AI Diabetes Food Tracker

Key Takeaways

The app functions as a digital health assistant that claims to simplify glucose management through image-based food analysis and personalized lifestyle insights.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by Gluco AI Diabetes Food Tracker, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “Gluco AI Diabetes Food Tracker Intelligence Report.” Updated Apr 24, 2026. https://marlvel.ai/intel-report/medical/com-srinjayverma-glucoai

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0